Brostallicin Hydrochloride

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameBrostallicin Hydrochloride
Drug Alias Name盐酸溴他利星brostallicine溴他利星盐酸盐brostalicinabrostallicinum +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitorsApoptosis stimulants
TargetsDNA
Therapy Area/IndicationsTriple Negative Breast NeoplasmsPlasmacytomaMultiple Myeloma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSystems Medicine LlcNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsTriple Negative Breast NeoplasmsPlasmacytomaMultiple Myeloma +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia